TI
RVMD icon

Tidal Investments’s Revolution Medicines RVMD Stock Holding History

Tidal Investments’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.4M Sell
109,096
-28,146
-21% -$4.11M 0.04% 461
2026
Q1 		$13.2M Buy
+137,242
New +$13.9M 0.03% 467

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Tidal Investments's RVMD Position: Q2 2026 in Review

Tidal Investments reduced its Revolution Medicines (RVMD) stake by 21% in Q2 2026, selling an estimated $4.11M and leaving 109,096 shares worth $20.4M. The position accounts for 0.04% of the portfolio, ranked #461.

Tidal Investments first reported a position in RVMD in Q1 2026 and has held it in 2 quarters since. 693 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Tidal Investments held 109,096 shares of Revolution Medicines worth $20.4M as of Q2 2026.
  • Tidal Investments sold 28,146 Revolution Medicines shares in Q2 2026, an estimated $4.11M.
  • Revolution Medicines made up 0.04% of Tidal Investments's portfolio in Q2 2026, its #461 holding.
  • Tidal Investments first reported a position in Revolution Medicines in Q1 2026 and has held it in 2 quarters since.
  • 693 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.